New Levels and Trends of AMR at a Level V Hosp
Starting on:
May 15, 2026
Ending on:
May 15, 2026
Moderator(s):
Dr. Edward Wasike
Consultant Pathologist
Venue:
DFMH Conference Hall
Max Credits:
3 Points

Provider:
Defence Forces Memorial Hospital
Claim Points

New Levels and Trends of AMR at a Level V Hosp

Starting on:
May 15, 2026
Ending on:
May 15, 2026
Venue:
DFMH Conference Hall

Description

This Continuing Medical Education (CME) session will provide an update on the emerging levels and trends of antimicrobial resistance (AMR) within a Level V hospital setting and their implications for patient care, infection prevention, and antimicrobial stewardship. The session will explore current resistance patterns among common bacterial pathogens, factors driving antimicrobial resistance, and the impact of inappropriate antimicrobial use on healthcare outcomes. Participants will review local microbiological surveillance data, antibiogram interpretation, and evidence-based strategies for optimizing antimicrobial prescribing practices. The session will also address the role of infection prevention and control (IPC), laboratory surveillance, multidisciplinary collaboration, and antimicrobial stewardship programs in combating AMR. Emphasis will be placed on strengthening healthcare workers’ capacity to recognize resistance trends, improve clinical decision-making, and promote rational antimicrobial use to preserve the effectiveness of available therapies.

Objectives

By the end of this CME session, participants will be able to: Describe current levels and emerging trends of antimicrobial resistance (AMR) within a Level V hospital setting. Identify common resistant pathogens and resistance mechanisms affecting patient management. Interpret antibiogram and microbiological surveillance data to guide empiric and targeted antimicrobial therapy. Recognize factors contributing to antimicrobial resistance, including inappropriate prescribing and infection control gaps. Apply principles of antimicrobial stewardship to improve rational antimicrobial use and patient outcomes. Strengthen infection prevention and control (IPC) practices to reduce the spread of resistant organisms within healthcare facilities. Promote multidisciplinary collaboration among clinicians, pharmacists, microbiologists, nurses, and IPC teams in addressing AMR challenges. Support evidence-based policies and continuous surveillance systems for monitoring and controlling antimicrobial resistance.

Presenters

Search For CPD Activity